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Abstract 
Available data indicate that there are gender differences in many features of 
Parkinson’s disease (PD). Precise identification of the gender differences is important 
in order to tailor treatment, predict outcomes and meet other individual and social 
needs in women and men with PD. The aim of this paper was to review the available 
clinical data on gender differences in PD.  
Original articles and meta-analyses published between 1990 and 2016 
systematically exploring gender differences in PD were reviewed. There is slight male 
preponderance in incidence and prevalence of PD. PD starts earlier in men. Women 
tend to be more prone to develop tremor-dominant PD but are less rigid than men. 
Motor improvement after deep brain stimulation is equal in both sexes but women 
tend to show better improvement in activities of daily living. Furthermore, women 
with PD show better results on tests for general cognitive abilities, out-perform men 
in verbal cognitive tasks, show more pain symptoms and score higher on depression 
scales. It seems, however, that the differences in cognition, mood, and pain perception 
are not disease specific since similar gender differences can be found in healthy 
subjects and in other neurological conditions.  
Despite PD being the most frequently studied movement disorder, studies 
investigating gender differences in PD are still scarce with most of the studies being 
cross sectional. Good quality, prospective, longitudinal studies analyzing gender 
differences in PD and comparing them to matched healthy controls are needed in 
order to properly address the issues of gender differences in PD.  
 Keywords: Parkinson's disease, gender differences, motor symptoms, non-
motor symptoms, quality of life, activities of daily living.   
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1. Introduction 
Parkinson’s disease (PD) is a chronic neurodegenerative disease. Its main 
pathological feature is degeneration of substantia nigra pars compacta (SNc) leading 
to reduced dopamine production.
1
 This, together with degeneration of other brain 
regions, subsequently leads to resting tremor, rigidity, brady-hypokinesia, and 
postural instability, which are the main motor manifestations of the disease.
2
 In 
addition, there is an abundance of non-motor symptoms (NMS), such as hyposmia, 
constipation, REM sleep behaviour disorder (RBD), pain, depression and cognitive 
disturbances that also contribute to disability in activities of daily living (ADL) and 
decreased quality of life (QoL).
3
 
Available data indicate that there are gender differences in many features of 
PD. Not only epidemiological characteristics of the disease differ between men and 
women with PD, but there are also differences in clinical presentation of both the 
motor and non-motor features of the disease.
4
 Taking these differences in 
consideration might help diagnosis, tailor treatment, predict outcomes and meet social 
and other needs in men and women with PD.
5
 Despite PD being the most frequently 
studied movement disorder, studies investigating gender differences in PD are still 
scarce. In addition, it is not clear how clinically relevant the already described gender 
differences in PD are in order to be used to differentially diagnose and treat PD. In 
this paper we will use the term gender in its broader sense – encompassing both the 
biological (i.e. sex) differences as well as the social, cultural and personal 
implications of what it means to be a woman or a man (i.e. gender), keeping in mind 
that both terms – sex and gender– have often been used interchangeably in the 
medical literature.
6
  
The main aim of this paper is to review the clinical studies systematically 
Page 3 of 33
Acta Neurologica Scandinavica - PROOF
Acta Neurologica Scandinavica - PROOF
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
PROOF
Gender differences in PD, a review  
 4
exploring gender differences in PD. Because of paucity of data, gender differences in 
other parkinsonisms are not reviewed here (Table 1
7-9
).  We will first look at the 
gender differences in epidemiology (incidence, prevalence, age at onset), and then 
move to gender differences in both motor and non-motor clinical presentations -  
(cognition, depression, anxiety, apathy, fatigue, pain, autonomic dysfunction, 
hyposmia, sleep) as well as explore differences in ADL/QoL measures and in 
treatment of PD.  
 
2. Materials and methods 
Search of the literature was performed on PubMed, Web of Science, and 
Scopus. The search terms included Parkinson’s disease, sex, gender, motor, non-
motor symptoms (cognition, depression, anxiety, apathy, fatigue, pain, autonomic 
dysfunction, hyposmia, sleep), epidemiology, demographic characteristics, activities 
of daily living, and quality of life. The criteria used to extract the relevant papers 
included original articles and meta-analyses systematically exploring gender 
differences in PD from 1990 to 2016.  
The search initially rendered 238 papers without duplicates. After excluding 
papers on basic and animal studies, 184 papers remained. Of these 62 met the criteria 
above and were included in this systematic review (see Table 1 for summary of 
studies and Table 2 for gender distribution of symptoms and signs). All authors 
approved the extraction of the relevant articles. 
 
3. Results and discussion 
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3.1 Gender differences in incidence, prevalence, age at onset and risk factors in 
PD patients 
In most of the studies reviewed here the number of men with PD outweighed 
the number of women (Table 1). The total number of women with PD in the reviewed 
articles was 12994 (41%), and the total number of men with PD was 18302 (59%). 
Indeed, one of the most commonly reported gender differences in PD is that women 
are less likely to get PD. For example, Baldereschi et al.
10
 reported greater incidence 
of PD in men (41.1/10,0000 annually) than in women (21.7/10,000 annually) 
including all age groups. This has been replicated in other studies.
11-13
 In addition, the 
prevalence is also higher in men than in women with PD (around 30/10,000 and 
24/10,000 respectively),
13-15
 and according to some studies, men have up to twice as 
higher risk than women to develop PD.
16-18
  
Regarding the age at disease onset, even though some studies have found that 
PD starts earlier in men,
19,20
 others showed no difference between sexes in mean age 
at PD onset and age at PD diagnosis.
21
 Similar findings were reported by Baba et al. 
2005
22
 and Scott et al.
23
 who also found no differences in age at disease onset and 
duration of symptoms before diagnosis, or disease duration from diagnosis between 
sexes.  Risk factors for PD did also differ in men and women; for example Savica et 
al.
24
 found that in men risks included lack of coffee consumption, head trauma, and 
exposure to pesticides, while anemia was a risk factor in women. In a recent study, 
high urate levels in men but not in women was associated with lower future risk to 
develop PD.
25
 Regarding gender differences in genetic risk factors to develop PD the 
studies are not consistent: while some studies report a female preponderance in 
leucine-rich repeat kinase 2 (LRRK2) positive PD,
26
 other studies did not find any 
gender differences.
27
 Interestingly, having a child with LRRK2 mutation seems to be 
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related to higher risk of PD in the parents, as does having a daughter no matter the 
genetic status of the offspring.
28
 Genetic influence might also have a gender specific 
effect on environmental risk factors such as smoking; for example, monoamine-
oxidase B (MAO-B) genotype was shown to have a modifying effect on the inverse 
relationship between smoking and PD in men, but not in women.
29
 In addition, there 
is also evidence that there might be gender-related differences in gene expression in 
human dopaminergic neurons in SNc (e.g. up-regulation of alpha-synuclein and 
PTEN induced kinase 1 (PINK1) genes in men, but not in women
30
), which might at 
least partially explain the gender differences in clinical presentation and response to 
treatment in PD.
31,32
 No gender differences in incidence/prevalence or other disease 
characteristics have been reported for parkin
33
 or glucocerebrosidase (GBA) genes.
34
 
 In conclusion, there is evidence suggesting that men are at higher risk to 
develop PD. The reason behind this is not well understood. Some data suggest that 
this might be related to the protective role of oestrogens in women,
35,36
 as the 
incidence of PD becomes more even across sexes in postmenopausal women.
37
 The 
gender difference in prevalence and incidence of PD might also result from  different 
profiles of risk factors, environmental
24
 and/or genetic.
26
 An alternative explanation 
may be that most studies rely on a ‘hospital-clinical population’, meaning that there 
may already be a selection bias at the point of patient recruitment, and even though 
women tend to be more prone to participate in research
38
 in many countries men may  
have better access to health care.
39
 When using ‘door to door survey’ methodology 
the figures seem to show either no gender difference in prevalence,
40,41
 or sometimes 
even higher prevalence of PD in women
42
 Furthermore, data concerning an earlier PD 
onset in men compared to women are not conclusive and need further clarification.  
3.2. Gender differences in motor symptoms, disease progression and 
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complications of dopaminergic therapy in PD patients  
As the motor symptoms still form the basis for PD diagnosis, it is interesting 
to evaluate gender differences in presentation of motor symptoms (Tables 1 and 2). 
Indeed, knowledge about possible gendered patterns in disease manifestation may 
make the diagnosis of PD in men and women easier. It seems that women experience 
later onset of motor symptoms
11
 and they are also more likely to present with tremor 
dominant PD.
20,43
 Tremor dominant PD is know to be associated with a slower and 
more benign disease progression,
1
 although the overall motor scores may not 
necessarily show gender differences.
20
 Women also show higher striatal dopaminergic 
activity
20,44,45
 and healthy women even show higher dopaminergic synthetic capacity 
compared to age-matched healthy men.
46
 Other motor symptoms such as writing 
difficulties and clumsiness were found to be less frequent in women than in men with 
PD.
23
 On the other hand, Augustine et al.
21
 did not find differences in motor 
symptoms and neither in time spent with dyskinesias nor in time spent “off” 
medication, or in occurrence of early morning dystonia. Similarly, Baba et al. 2005
22
 
did not find gender differences in the distribution of tremor and bradykinesia in the 
initial phase of PD, although a higher proportion of women showed a Hoehn and Yahr 
(H&Y) score above three suggesting more advanced disease at inclusion in women. 
Furthermore, even though there was no gender difference in the overall motor scores 
of the Unified Parkinson’s Disease rating Scale (UPDRS), women had worse scores 
in postural instability and had lower rigidity scores,
13,43,47
 while the rate of disease 
progression was similar in both sexes.
22
 Greater overall severity of motor symptoms 
in men and worse dyskinesias in women, despite lower L-dopa equivalence daily dose 
(LEDD)
13,22,47-49
 (see Umeh et al.
50
 for alternative findings) have also been shown in 
other studies.
47,51
 In addition, dyskinesias in women occurred earlier after disease 
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onset than in men.
52
 
Other drug-related motor phenomena are also reported to be more frequent in 
women. For example, Colombo et al.
53
 found a higher prevalence of wearing-offs 
(WOFs) in women, which together with higher rate of dyskinesias and shorter latency 
to develop dyskinesias might be explained by greater L-dopa bioavailability
54
 and 
better response to L-dopa in women.
51
 Similar findings were reported in other 
studies.
55,56
 However, despite higher L-dopa bioavailability in women with PD, 
Kompoliti et al.
55
 did not find gender differences in bioavailability of pramipexole, 
and found no difference in clinical improvement after L-dopa administration. No 
gender differences in motor symptoms but higher proportion of non-motor 
fluctuations in women with PD were recently reported by Picillo et al. 2016.
57
 
In conclusion,, it seems that women with PD may have more favorable disease 
profile since motor symptoms emerge later, tremor is more common as first 
presenting symptom
20
 and women with PD tend to be less rigid
22
 Some data, 
however, suggest that women are more prone to develop postural instability than 
men.
22
 Even though treatment with dopamine agonists (DA) does not differ between 
men and women,
50
 it seems that L-dopa related motor complications, such as 
dyskinesias and WOFs are more common in women with PD.
53
  
 
3.3. Gender differences in non-motor symptoms, and other disease 
characteristics in PD patients  
In addition to the motor symptoms and signs, non-motor symptoms (NMS) 
and signs form an integral part of the disease manifestations.
58
 Possible gender 
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differences in NMS in PD patients
59,60
 could substantially improve the gender-specific 
approach in diagnosis and treatment. In addition, NMS do indeed affect patients’ 
ADL and QoL.  
 
3.3.1. Gender differences in cognition 
According to Augustine et al.
21
 men show worse cognitive abilities as 
measured by the overall scores on the Symbol Digit Modalities and the Scale for 
Outcome of Parkinson Disease Cognition. Worse general cognitive abilities in men 
with PD have been reported in other studies as well
47,61
 It seems that there is also 
domain specific gender difference patterns in cognition, such that men with PD show 
worse performance on verbal memory tests but better visuospatial abilities.
61,62
 
Similar pattern (i.e. faster psychomotor speed and higher verbal memory and learning 
in women, but better visuospatial abilities in men) has been reported in healthy 
elderly men,
61,63
 in patients with mild cognitive impairments without PD
64,65
 and in 
patients with Alzheimer’s disease,
65
 although some may dispute the validity of these 
test results in female healthy population (e.g. that tests of spatial abilities are not 
gender neutral
66
). Contrary to these findings Gao et al.
51
 found lower scores on a 
number of cognitive tests in women with PD: in addition to the cognitive domains 
“traditionally” being reported to be better in men (visuospatial or mathematical 
abilities), men with PD performed better than women on vocabulary tasks as well. 
However, in this study men had a higher level of education than women with PD. 
Furthermore, Foltynie et al.
67
 investigating the effect of different alleles for the 
Val
66
Met polymorphism for the Brain Derived Neurotrophic Factor (BDNF) gene, 
found that women with PD with Met alleles for the gene performed better on the 
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Tower of London test, suggesting better executive functions in female patients carriers 
of the Met allele. Interestingly, Caranci et al.
68
 found association between lower 
plasma levels of alpha synuclein and cognitive impairment, hallucinations, psychosis 
and apathy in men with advanced-stage PD, but not in women.  
 
3.3.2. Gender differences in depression, anxiety, apathy, fatigue and pain 
Baba et al. 2005
22
 reported a significantly higher proportion of depression in 
women with PD. Similar findings have been reported in other studies
13,23,43,51,69-72
, 
even though this has not been always replicated.
73
 As a matter of caution, it is well 
known that in general, women are more prone to develop depression.
74,75
 Interestingly 
in a 2-years follow-up study Picillo et al. 2014
48
 found significant reduction of 
depression in both sexes. Higher anxiety level,
43,51,61,70,72
 higher prevalence of 
fatigue
43,69
 and higher proportion of NMS fluctuations (despite no difference in 
LEDD)
57
 in women with PD has also been consistently reported. Meyer et al.
76
 found 
that older age correlated positively with apathy in men, but negatively in women, 
suggesting a reduced risk of apathy in older women. It also seems that PD related 
pain symptoms are more prevalent in women
13,23,69
, which again might not be disease 
specific as this can be seen also in the general population.
77,78
 
 
3.3.3. Gender differences in sleep/REM-sleep behaviour disorders (RBD) 
Bjørnara et al.
79
 explored the gender differences with regards to RBD. 
Although the prevalence of RBD was higher in men, the difference was not 
significant. A higher prevalence of RBD in men with PD has been reported in other 
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studies as well,
47
 with men showing more fights, violent behaviour and awaking by 
own movements. Male preponderance has also been noted in idiopathic RBD. 
80
 
Other studies have, however, reported higher rate in night-time sleep disturbances in 
women with PD.
13
 
 
3.3.4. Autonomic dysfunction and hyposmia 
It seems that sexual dysfunction is more prevalent in men with PD.
13,43,47,70,72
 
Related to this, compulsive sexual behavior, a part of the impulse control disorders 
(ICD) spectrum, is known to be more frequent in men with PD.
81
 In addition to low 
dopamine agonist dose, female gender was found to be a good prognostic factor for 
ICD resolution.
82
 Unlike men, women with PD are more prone to develop impulsive 
shopping and binge eating.
81
 Urinary symptoms have been reported to be more 
frequent in men,
48,69
 which holds true also for hyposmia.
61,72
 On the other hand, 
orthostatic hypotension, cardiovascular problems
13
 and weight loss
83
 have been found 
to be more common in women with PD, although these results (e.g. orthostatic 
hypotension) are not unequivocal.
47
 
 
3.3.5. Activities of daily living (ADL) and quality of life (QoL) 
 Lubomski et al.
84
 evaluated the gender differences in QoL related to motor 
symptoms in PD. In this study, men reported a greater disease burden than women as 
noted by higher UPDRS-III scores, higher LEDD and higher reliance on caregivers. 
The Parkinson’s Disease Questionnaire (PDQ-39) showed men having lower QoL in 
the ADL, cognition and communication domains. On the other hand, Baba et al. 
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2005
22
 found worse ADLs in women with PD; however improvement of ADL in 
women after deep brain stimulation (DBS), has been shown to be greater than in men 
with PD.
85,86
 Lower QoL in women with PD has been reported in other studies as 
well.
13,87
  
 In conclusion, there is strong evidence that NMS profiles differ between men 
and women with PD. One of the most consistent gender differences in the NMS in PD 
are in the cognitive abilities; it seems that women with PD show better global 
cognitive abilities than men.
61
 While women with PD usually perform better on verbal 
memory and learning tests, men have better visuospatial abilities.
61
 However, it is 
important to note again that similar pattern of gender-specific differences in cognitive 
abilities has been described not only in patients with other neurological disorders.
64,65
 
but also in healthy subjects,
61,63
 . Similarly, higher level of depression and anxiety in 
women is not PD-specific
48,61,72
 since it is also seen in the general population.
74,75
 In 
addition higher prevalence of chronic pain states and greater pain sensitivity among 
women in the general population has also been repeatedly reported.
77,78
 Sexual 
dysfunction and urinary difficulties are more common in men with PD. In general, the 
overall QoL and ADL might be more affected in women with PD.
84-86
 
 
3.4. Gender differences in PD patients treated with stereotactic surgery 
There are only few studies reporting gender differences in patients treated with 
stereotactic surgery. In a meta-analysis Hariz G-M et al. 2011,
88
 (see also Hariz G-M 
et al. 2003,
86
 Kenny et al. 2007,
89
 and Chiou et al. 2015
90
) evaluated the distribution 
of PD patients treated with subthalamic nucleus (STN) deep brain stimulation (DBS). 
They screened 135 publications with respect to the gender distribution of patients 
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treated with STN DSB across different continents. Patients´ gender was specified in 
119 papers (88%), encompassing a total of 3880 patients, of whom 2445 (63%) were 
men. Hence the number of men with PD treated with stereotactic surgery in this meta-
analysis exceeded the “usual” male/ female predominance in PD.
10
 In an earlier study 
Hariz G-M et al. 2003
86
 explored the gender differences in QoL measures in PD 
patients before and after stereotactic treatment for PD. Before surgery women had a 
longer disease course, higher stage of disease on the H&Y scale, higher scores of  
UPDRS-II (ADL) and IV (complications of therapy), worse scores on the ADL 
taxonomy and on Schwab and England ADL scale. Even though motor improvement 
was similar in both sexes (see also Hariz G-M et al. 2003,
86
 Accolla et al. 2007,
49
 and 
Chiou et al. 2015
90
 for gender-related equal motor improvement), 11 months after 
surgery women showed significantly better improvement in ADL, emotions and 
social life. This was replicated in later studies from the same,
85
 and other groups.
49
 In 
addition, while lower LEDD, higher motor dysfunction (particularly tremor), and 
greater improvement in tremor and rigidity on L-dopa challenge test were found to 
predict better operative outcome in men with PD
90
 , better ADL scores, despite higher 
preoperative motor scores,  predicted better operative outcome in women with PD.
90
  
 In summary, the evidence from the studies on gender differences in PD 
patients treated with stereotactic surgery suggest that men are more likely than 
women to access surgical treatment,
85
 which may be related to a gendered referral 
bias for surgery favoring men,
88
 or due to women declining surgery.
91
 Interestingly, 
despite the same motor improvement across sexes,
85
 QoL measures and ADL improve 
more in women than in men, although women have longer disease duration before 
surgery than men.
85,92
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4. Conclusions and directions for future research 
The aim of this paper was to review clinical studies exploring the gender 
differences in PD. The data from the studies reviewed here indicate that there are 
many potential markers for gender differences in PD. Candidate markers sensitive to 
gender differences in PD can be found not only amongst epidemiological 
characteristics and the motor symptoms, but also amongst non-motor symptoms of the 
disease. In addition, data also suggest differences in QoL and ADL measures of PD 
(Table 2).  
Summarizing, one of the best established disease characteristics that shows a 
gender specific effect is the slightly higher incidence and prevalence of PD among 
male subjects.
10
 In addition, it seems that PD starts earlier in men compared to women 
possibly due to the protective effect that oestrogen has in pre-menopausal women.
20
 
Women more often show tremor-dominant PD at disease onset compared to men.
20
 It 
also seems that women are less rigid
22
 but display more postural instability than 
men.
22,43
 Even though the therapy scheme and LEDD seem to be similar in men and 
women with PD,
50
 (or sometimes reported to be even higher in men,
22
 probably due to 
better bioavailability of L-dopa in women than men) women are more prone to 
develop dyskinesias than men.
22,43
 Regarding NMS in PD, while in general women 
show better results on measures of general cognitive abilities as well as on verbal 
memory and executive tasks, 
61
 men show better visuospatial cognitive abilities.
61
 On 
the other hand, women with PD show higher level of depression and anxiety.
22
 These 
findings should, however, be interpreted with caution, since a similar gender specific 
pattern concerning these non-motor domains has been reported in the healthy 
population,
61,63,74,75,77,78
 as well as in patients with other neurological conditions.
64,65
 
Even though response of motor symptoms to DBS seems to be similar in men and 
women with PD, ADL improve more in women.
85
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There are few important issues that have to be taken into consideration when 
planning future research on gender differences in PD: controlled, prospective, 
longitudinal studies specifically looking at the issue of gender differences in clinical 
presentation of PD (see Picillo et al. 2014,
48
 a short-term follow-up study on gender 
differences in PD) are lacking. Possible changes over time might be expected not only 
quantitatively (i.e. severity of symptoms), but also in the quality/ gender-related 
pattern of symptoms and signs. This can also trigger potential research on the basic 
mechanisms that underlie these changes.
93
 Furthermore, it is important to compare 
results in PD with matched healthy subjects, as many characteristics that account for 
the gender differences seen in general population are also reflected in PD.
61
 
Therefore, future studies on the gender differences in PD (and other neurological 
disorders) should always include comparison with matched healthy controls, as this 
may have important implications for the interpretation of gender differences in PD 
and other neurological conditions.  
Aside from this review, good quality basic studies specifically exploring the 
issue of gender differences in PD at different levels – molecular, cellular, network, 
and system level are needed. For example, there are only few studies on gender 
differences in the electrophysiological characteristics of the disease.
94
 There is also 
lack of studies directly correlating possible basic mechanisms and clinically 
observable gender differences in PD (translational research). Therefore, good quality 
(basic and clinical) studies on gender differences in PD may lead to identification of 
reliable gender-sensitive markers that can be used to approach patients in a gender-
specific manner - from diagnosis, through treatment to addressing socioeconomic 
issues related to PD. Indeed, there is a continuous need for research about gender bias 
in medical investigations and treatments in everyday clinical practice in general
95
 with 
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a final aim to better improve the quality of life and wellbeing of all patients, 
irrespective of gender.  
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 First author, 
year [Ref No] 
Participants Main objectives/ Study type DEM MS NMS ADL/ 
QoL 
Summary of main gender-related results 
F: N (%) M: N (%) 
1 
 
Accola et al. 
200749 
16 (42) 22 (58) To evaluate gender differences 
in STN-DBS PD patients before 
and 1 year post-op/ Prospective 
controlled study 
X X X X Higher improvement of ADLs in women 
2 Augustine et 
al. 201521 
 
618 (31) 1,123 (63)  To evaluate gender differences 
in PD/ Cross sectional study 
X X X X No gender difference in age at disease onset, women performed better on 
cognitive tests (SCales for Outcomes in PArkinson's disease-COGnition  -
SCOPA-COG) 
3 Alves et al. 
200911 
85 (41) 122 (59) To explore gender differences 
and incidence of PD/ 
Longitudinal study 
X X   Standardized male to female ratio 1.58 with a consistent male preponderance and 
an incidence of 15.6/105yr-1 in men and 9.9/105yr-1 
4 
 
Baba et al. 
200522 
420 (33) 
 
844 (67) 
 
To evaluate gender differences 
in PD/ Cross sectional study 
X 
 
X X 
 
X 
 
Women were more depressed, more affected ADL and had worse postural 
stability; men had higher rigidity score 
5 Baba et al. 
20067 
PSP: 68 (56)  PSP: 53 (44)  To evaluate sex differences in 
PSP/ Cross sectional study 
X X   Men had higher tremor score and higher body-mass index 
6 
 
Baldereschi et 
al. 200010 
 
29 (69) 13 (31) To determine incidence of 
parkinsonism and PD/  
Longitudinal study 
X    Men showed higher PD prevalence in all age groups 
7 Bergareche et 
al. 200440 
PD:12 (66) 
OP: 7 (50) 
PD: 6 (33) 
OP: 7 (50) 
Door-to-door survey of PD and 
other parkinsonisms 
X    No gender difference in prevalence of PD  
8 
 
Bjørnarå et al. 
201379 
42 (39.2) 68 (63.5) To examine possible PD gender 
differences with regards to 
RBD symptoms/ Controlled 
study 
 X X  More women experienced disturbed sleep, more men experiences fights, violent 
behaviour and awakings by own movements 
9 Cantuti-
Castelvetri et 
al. 200730 
PD: 4 (50) 
HC: 4 (50) 
PD: 4 (50) 
HC: 4 (50) 
To evaluate gender-specific 
gene expression in PD/ In vitro 
post mortem study 
    Alpha-synuclein and PINK1 genes in   substantia nigra upregulated in men, but 
not in women with PD 
 
10 Caranci et al. 
201368 
PD: 40 (57) 
HC: 53 (51) 
PD: 29 (43) 
HC: 50 (49) 
To examine PD gender 
differences in alpha-synuclein 
plasma concentrations/ 
Controlled study 
X  X  Plasma alpha-synuclein concentrations in advanced PD decreased in men 
11 Caslake et al. 
20148 
VP: 14 (37) 
PSP: 3 (18) 
MSA:10 (50) 
VP: 24 (63) 
PSP:14 (82) 
MSA: 10 (50) 
To examine demographic 
characteristics of degenerative 
and vascular parkinsonisms/ 
Cross sectional study 
X    Age adjusted male to female ratios for VP 2.58, 1.49 for PSP and 8.65 for MSA. 
No differences in other clinical or socio-demographic data 
12 
 
Carey et al. 
200262 
PD: 10(50) 
HC:10(50) 
PD: 10 (50) 
HC:10 (50) 
To examine possible PD gender 
differences in tracking 
performance/ Controlled study 
  X  No gender difference in tracking performance in PD 
13 Chahine et al. 
201334 
 
80 (30) 182 (70) To examine clinical and 
biochemical differences in PD 
in GBA mutations/ 
Epidemiological study 
X X   No gender differences, GBA patients have earlier age at onset and are more 
likely to demonstrate cognitive deficit.  
14 
 
Chiou et al. 
201590 
48 (66) 24 (34) To examine gender differences 
in motor symptoms in STN-
DBS PD patients/ Prospective 
X    Women had slightly lower MMSE scores and better response to L-dopa before 
operation; no gender differences in the response of motor symptoms to STN-
DBS  
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study 
15 Cilia et al. 
201426 
1488 (59) 1053 (41) To investigate whether or not 
LRRK2 status influences 
gender distribution/ Cross 
sectional study 
X    More female carriers of LRRK2, women more often reported positive family 
history; no gender differences in clinical presentation of PD 
16 Colombo et 
al. 201553 
236 (38) 381 (62) To explore the gender 
differences in wearing offs 
(WOFs) in PD/ Cross sectional 
study 
 X   WOFs were more common among women 
17 de Lau et al. 
200417 
36 (53) 31 (47) To explore demographic and 
gender differences in incidence 
for PD/ Longitudinal study 
X    Higher incidence in men with a male to female ratio of 1.54 (CI, 0.95 to 2.51). 
The study initially included 6,839 subjects (The Rotterdam study) 
18 de Rijk et al. 
199741 
182 (56) 138 (44) To test the prevalence of PD in 
Europe/ Door-to-door survey 
X    No difference in prevalence; EUROPARKINSON multicenter collaborative 
study comprising 17,205 elderly subjects 
19 Elbaz et al. 
200216 
65 (42) 89 (58) To explore incidence rate in 
PD/ Epidemiological study 
X    Higher lifetime cumulative incidence for men (2.0) as compared to women (1.6) 
20 Foltynie et al. 
200567 
115 (40) 176 (60) 
 
To explore the effect of BDNF 
gene Val66met polymorphism 
on cognition in PD/ Cross 
sectional study 
  X  BDNF polymorphism had significant impact on cognition in women, but not 
men 
21 Gan-Or et al. 
201527 
2541 (40) 3986 (60) 
 
To search for a possible gender 
effect of LRRK2 mutations/ 
Meta-analysis  
 
    1:1 male to female ratio in LRRK2-associated PD 
 
22 Gao L et al. 
201551 
139 (44) 172 (56) To investigate the sex 
differences in a cohort of PD 
patients/ Cross sectional study 
X X X 
 
 Better cognitive performance in men; tremor dominant PD more common in 
women. Women showed greater response to L-dopa and had a higher rate of 
dyskinesias 
23 Gao X et al. 
201625 
186 (48) 202 (52) 
 
To investigate gender effect of 
plasma urate concentration in 
PD/ Cross sectional study 
    Men with higher plasma urate concentrations had a lower future risk developing 
PD 
24 Guo et al. 
201369 
226 (43)  
 
296 (57)  
 
To investigate gender 
differences in PD/ Cross-
sectional study 
 X X  Women had more sleep, fatigue, mood and pain symptoms; men had more 
urinary problems 
25 Hariz  GM et 
al. 200386 
14 (37) 24 (63) To evaluate QoL parameters in 
PD after sterotactic surgery/ 
Prospective controlled study 
X X X X Longer disease course, higher H&Y score, more dyskinesias, better ADL profile 
and higher improvement in ADL after surgery in women 
26 Hariz  GM et 
al. 201188 
1435 (37)  2445 (63) Meta-analysis of studies on 
gender differences in PD treated 
with neurosurgical procedure  
X    Men are more likely to get a neurosurgical treatment for PD 
27 Hariz GM et 
al. 201385 
18 (36) 31 (64) To evaluate gender differences 
in quality of life in STN-DBS 
PD patients/ Prospective 
controlled study 
X X  X A better improvement in QoL in women, no difference in improvement of motor 
scores 
28 Hassin-Baer 
et al. 201152 
65 (42) 90 (58) To identify factors associated 
with development of 
dyskinesias/ Cross sectional 
study 
X    Women developed dyskinesias in shorter time (4 y in women vs. 6 in men) 
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29 Haaxma et al. 
200720 
99 (39) 154 (61) To investigate the gender 
differences in PD/ Cross 
sectional study 
X X   Women were older at disease onset, showed more tremor dominant phenotype 
and higher striatal traces uptake on DATScan 
30 Joutsa et al. 
201282 
109 (38) 181 (62) To investigate the prognostic 
factors for ICD resolution/ 
Cross sectional study 
  X  Female gender was been found to be a good prognostic factor for ICD resolution 
31 Kelada et al. 
200229 
PD: 73 (39) 
HC: 103 (35) 
PD: 113 (61) 
HC: 193 (65) 
 
 
To test if gender can modify the 
associations between smoking, 
MAO-B intron 13 genotype, 
and PD 
X    MAO-B intron 13 genotype has an effect on the inverse relation between 
smoking and PD in men, but not in women 
32 Kim et al. 
201459 
74 (40) 108 (60) To investigate NMS gender 
differences in PD/ Cross 
sectional study  
X X X  Different profile of NMS in men and women with PD defined by different 
content of clusters 
 
33 Kompoliti et 
al. 200255 
14 (53) 12 (47) To study sex differences on the 
phar- macokinetics of L-dopa 
and paramipexole/ Cross 
sectional study 
    Postmenopausal women had higher bioavailability of L-dopa; no gender 
difference in bioavailability of paramipexole, no difference in clinical 
improvement after levodopa 
34 Kotagal et al. 
201344 
36 (25) 112 (75) To investigate gender 
differences in dopaminergic and 
cholinergic denervation in PD/ 
Cross sectional study 
    Men showed greater caudate dopaminergic denervation and greater neocortical 
cholinergic denervation than women 
 
35 Kovacs et al. 
201613 
361 (58) 360 (42) To investigate NMS sex 
differences in PD/ Cross 
sectional study 
X X X 
 
 
 PD more prevalent in men; man had higher dose of DM, and more sexual 
problems; women had worse postural instability, gait disabilities, and 
dyskinesias, and worse non-motor symptoms and HRQoL 
36 Kumagai et al. 
201454 
77 (60) 
 
51 (40) To test gender differences in 
bioavailability of L-dopa/ 
Interventional clinical study 
X    Women have a greater bioavailability of L-dopa than men 
37 Laakso et al. 
200246 
HC:12 (34)  HC: 23 (66)  To test the hypothesis of higher 
presynaptic dopamine function 
in healthy women by [18F]F-
DOPA PET/ Cross sectional 
study 
    Healthy premenopausal women have a higher striatal presynaptic dopamine 
synthesis capacity than healthy men; a relative decrease in dopamine activity 
with age in men but not in women 
38 Lee et al. 
201545 
155 (51) 
 
152 (49) To compare gender differences 
in DAT activity by using 18F-
FP-CIT in healthy subjects 
    Women showed greater DAT activity in the striatum; age-related DAT decline 
was greater in the striatum in women 
39 Linder et al. 
201012 
76 (54) 62 (46) To investigate the incidence of 
parkinsonism/ Cross sectional 
study 
X X X X Higher incidence of PD in men (male to female ratio=1.2); higher H&Y score in 
women 
40 Liu et al. 
201561 
PD: 145 (35) 
HC: 67 (35) 
PD: 269 (65)  
HC 121 (65)  
To examine gender differences 
in non-motor symptoms of drug 
naïve PD patients/ Cross 
sectional study 
X X X X Men had significantly more olfaction deficits and worse global and verbal 
cognitive performance; women were more depressed and showed worse 
visuospatial deficits. Similar cognitive profile in HC 
41 Lubomski et 
al. 201484 
81 (38) 
 
129 (62) To evaluate gender differences 
in PD/ Cross sectional study 
X  X X Men had higher motor scores, higher daily dopaminergic medication intake, 
lower QoL, worse ADLs and showed higher impact of disease on overall life.  
42 Marceglia et 
al. 200694 
 
12 (50) 12 (50) To explore gender differences 
in LFP activity in STN in PD 
patients/ Controlled study  
    LFP recordings at rest without DM showed significantly higher power in the 
alpha ⁄ low-beta band in women and also had higher increase in high gamma 
activity after dopaminergic medication 
43 Martinez- 123 (51) 120 (49) To determine if smoking or X    Female gender, but not smoking delayed disease onset 
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Rumayor et 
al. 200919 
other factors (sex) determine 
age at PD onset/ 
Epidemiological study 
44 Martinez-
Martin et al. 
201270 
 
356 (37) 595(63)  
 
To explore gender differences 
in NMS in PD patients/ Cross 
sectional study 
X X X X Women reported more fatigue, were more depressed and anxious, and had more 
pain; men had more sleeping and sexual problems 
45 Moore et al. 
200587 
55 (45) 
 
69 (55) To explore the effect of gender 
identity on quality of life in PD/ 
Cross sectional controlled study 
X   X The QoL of androgynous PD women was significantly better than the 
androgynous PD men group 
46 Nicoletti et al. 
200342 
3 (60) 2 (40) To explore the demographic 
characteristics of PD/ Door-to-
door survey 
X    In the population aged 40 years and above prevalence was higher in women than 
in men (323 and 248/100,000, respectively)  
 
47 Nishioka et al. 
201033 
38 (13)  193 (83) To compare clinical 
characteristic between 
genetically neutral PD and PD 
related to LRRK2, PKAN1 and 
parkin mutations/ Cross 
sectional study 
X X   No gender differences related to genes found 
48 Picillo et al. 
201372 
PD: 74 (37)  
HC: 33 (35) 
PD: 126 (63)  
HC: 60 (65) 
To explore the gender 
differences in NMS in PD drug 
naïve patients/ Cross sectional 
study 
X  X  Men with PD reported more sex and taste/smelling difficulties  
 
49 Picillo et al. 
201448 
48 (35)  86 (65)  To explore gender differences 
in PD patients in 2 years 
follow-up period/ Longitudinal 
follow-up study 
X X X  Men had higher LEDD doses, and complained of greater number of NMS; 
Men reported more urgency, daytime sleepiness, weight change and sex drive. A  
reduction of mood/depressive symptoms in both sexes.   
50 Picillo et al. 
201657 
16 (34) 31 (66) To evaluate the gender 
differences in non-motor 
fluctuations in PD/Longitudinal 
prospective study 
 X X  Women had higher motor UPDRS scores, and had more non-motor fluctuations 
compared to men, no differences in motor fluctuations 
51 Saunders-
Pullman, et al. 
201128 
82 (46) 
 
93 (54) To test whether there is an 
increased genetic component  
(LRRK2 G2019S) of PD in 
women of Jewish background/ 
Cross sectional study 
    Having a daughter with PD associated with increased risk of parkinsonism in the 
parent as was having a child with a LRRK2 G2019S mutation 
52 Savica et al. 
201324 
75 (38)  
 
121 (62)  
 
To explore the gender 
differences in risk factors in 
PD/ Retrospective study 
    Risk factors for PD and their interactions may differ in men and women. In men 
independent effects of lack of coffee consumption, head trauma, and pesticide 
use; in women, anemia was the most important risk factor 
 
53 Scott et al. 
200024 
356 (37.8) 587 (62.2) To explore gender differences 
in PD patients at disease onset 
and at present/ Longitudinal 
study 
X  X  At disease onset, women reported neck-pain and low back pain more frequently 
than men; 9.3 years later, men reported more writing difficulties, gait problems, 
speech problems, increased flow of saliva, and lack of initiative 
54 Solla et al. 
201243 
PD: 65 (42)  
HC: 51 (38) 
PD: 91 (58)  
HC: 81 (62) 
 
To explore gender differences 
in PD/ Cross sectional study 
X X X 
 
 Women were more likely to present with tremor and had worse UPDRS 
instability score; NMSS score was significantly higher women; more frequent 
anxiety, depression, fatigue and sleep problems in women, more sexual problems 
in men 
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Table 1. Summary of studies (first author, year and Ref No=reference number as shown in the reference list) reviewed in the paper. Number and percentage of 
male and female PD patients (not marked or marked as “PD”) and healthy controls (HC) where appropriate, main objectives and main outcome by domain 
(DEM-demography, MS-Motor Symptoms, NMS-Non-Motor Symptoms, ADL/QoL=Activities of daily living and Quality of Life) as well as summary of the 
main gender-related results are presented in the table. 
 
HC=Healthy Controls, H&Y=Hoehn & Yahr scale, HRQoL=Health related quality of life, Examination, F=female, LEDD=Levodopa equivalence daily dose, 
LFP=Local Filed Potentials, LRRK2 = Leucine-rich repeat kinase 2, M=male, MAO-B=Monoamine oxidase B, MMSE=Mini Mental State, MSA=Multiple 
System Atrophy, STN-DBS = Subthalamic Nucleus Deep Brain Stimulation, PD= Parkinson’s Disease, QoL=Quality of Life, PINK1= PTEN induced kinase 
1; PSP=Progressive Supranuclear Palsy, VP=Vascular parkinsonism  
55 Song et al. 
201471 
170 (40) 
 
258 (60) 
 
To explore gender differences 
in PD/ Cross sectional study 
X  X 
 
 No gender differences in motor symptoms; women were more depressed, while 
men higher MMSE scores and lower scores for identification on Alzheimer's 
Disease Assessment Scale-cognitive subscale 
56 Szewczyk-
Krolikowski 
et al. 201447 
PD:184 (38) 
HC: 111 (63) 
PD: 306 (62) 
HC: 65 (36) 
To explore the effect of age and 
gender in PD/ Cross sectional 
study 
X X X  Men showed increased severity and greater symptom symmetricality in the face, 
neck and arms and women had more postural problems. Men showed worse 
cognitive dysfunction, greater rate of REM behavior disorder, more orthostatic 
hypotension and sexual dysfunction, women had more dyskinesias despite higher 
LEDD in men.  
57 Umeh et al. 
201450 
618 (35) 
 
1123 (65) To explore gender differences 
in types and frequency of drugs 
used in PD/ Cross sectional 
study 
    No gender differences in the type and dose of dopaminergic medications used in 
early PD 
 
58 Van Den 
Eeden et al., 
200318 
230 (40) 358 (60) To explore the variations of PD 
regarding age, gender and 
ethnicity/ Cross sectional study 
X    The rate to develop PD was 91% higher in men  
59 van der Hoek 
et al. 201173 
102 (40) 154 (60) To explore the effect of disease 
stage, motor subtype and gender 
on depression in PD/ Cross 
sectional study 
X  X  No gender differences in depression 
60 Walker et al. 
201283 
28 (51) 27 (49) To calculate the gender 
differences and 1-year survival 
rates in PD patients/ Clinical 
controlled study 
X    Outcomes for men with PD who have clinically important weight loss are poorer 
than for women 
 
61 Wooten et al. 
200415 
882 (48) 955 (52) A meta-analysis with the aim to 
calculate the gender related 
incidence of PD based on 7 
studies. 
X    A 1.5 fold higher incidence of PD in men than women 
62 Yamayoto et 
al. 20149 
27 (42) 37 (58) To explore the gender 
differences in urinary symptoms 
in MSA/ Retrospective study 
  X  Men had more nighttime urinary frequency and more severe voiding symptoms 
at disease onset 
Σ  PD: 12994 (41) PD: 18302 (59) / 43 23 26 10 In the reviewed studies, men with PD (59%) outnumbered women with PD 
(41%); 43 studies reported demographic data, 23 motor, whereas 26 non-motor 
symptoms/signs of PD. The QoL/ADL was specifically reported in 10 studies 
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 Symptom/Sign/Disease feature F  M Representative references 
1. Incidence and prevalence Lower < Higher Baldereschi et al. 2000,10 Alves et al. 2009,11 Kovacs et al. 2016,13 but see Bergareche et al. 2004,40  de Rijk et al. 
1997,41 Nicoletti et al. 200342 no gender difference 
2. Age at disease onset Later > Earlier Haaxma et al. 2007,20 but see Baba et al. 2005,22 Scott et al. 200023 no gender difference 
3. Disease progression Slower < Faster Haaxma et al. 2007,20 Scott et al. 2000,23 but see Baba et al. 200522 no gender difference 
4. Bradykinesia  Less < More Accolla et al. 200749 
5. Tremor More  > Less Haaxma et al. 2007,20 Solla et al. 201243 
6. Rigidity Less < More Baba et al. 200522 
7. Postural instability  More  > Less Kovacs et al. 2016,13 Baba et al. 2005,22 Solla et al 2012,43 Szewczyk-Krolikowski et al. 201447 
8. Dyskinesias More  > Less Kovacs et al. 2016,13 Baba et al. 2005,22  Colombo et al. 201553 
9. Other complications of dopaminergic therapy (wearing-offs) More > Less Colombo et al. 2015,53 for motor fluctuations, Picillo et al. 201657 for non-motor fluctutaions 
10. L-dopa equivalence dose Lower < Higher Kovacs et al. 2016,13 Baba et al. 2005,22 Picillo et al. 2014,48  but see Umeh et al. 201450 no gender difference 
11. General cognitive abilities Better > Worse Augustine et al. 2015,21 Liu et al. 2015,61 but Gao L et al. 2015,51 Song et al. 201471 
12. Verbal memory Better > Worse Liu et al. 201561 
13. Visuospatial cognitive abilities Worse < Better Liu et al. 201561                                                                                                                 
14. Executive functions Better > Worse Foltynie et al. 201567 
15. Depression More > Less Kovacs et al. 2016,13 Baba et al. 2005,22 Guo et al. 2013,69 Picillo et al. 2013,72 Song et al. 201471 
16. Anxiety More > Less Liu et al. 2015,61 Picillo et al. 201372 
17. Sleep quality, RBD Better > Worse Bjørnara et al. 201379 
18. Osmic abilities Better > Worse Liu et al. 201561 
19. Urinary difficulties  Less < More Guo et al. 201369 
20. Sexual dysfunction  Less < More Szewczyk-Krolikowski et al. 2014,47 Picillo et al. 201372 
21. Orthostatic hypotension  Less < More Szewczyk-Krolikowski et al. 201447 
22. Pain More > Less Scott et al. 200023 
23. QoL Lower  < Higher  Baba et al. 2005,22 Lubomski et al. 2014,84 Hariz GM et al. 2013,85 Hariz GM et al. 200386 
24. ADL Lower < Higher Baba et al. 2005,22 Lubomski et al. 2014, 84 Hariz GM et al. 2013,85 Hariz GM et al. 200386 
25. Availability of operative (stereotactic) treatment including DBS Lower  < Higher Hariz GM et al. 201188 
 
Table 2. Gender-specific distribution of motor, non-motor symptoms and other disease features most frequently reported in studies in PD patients; 
ADL=Activities of daily living, DBS=Deep brain Stimulation, F=Female, M=Male, RBD=Rem Sleep Behaviour Disorder, QoL=Quality of life.  
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